Dr. Reddy's Recalls Divalproex Sodium Tablets for Dissolution Failure
Dr. Reddy's Laboratories is recalling 5,160 bottles of Divalproex Sodium Extended-Release Tablets because they failed to meet dissolution specifications.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which is a reasonable probability of temporary or medically reversible adverse health consequences. The hazard is a quality control failure (dissolution) rather than a direct contamination or acute injury risk.
Plain-English summary
Dr. Reddy's Laboratories, Inc. is recalling 5,160 bottles of Divalproex Sodium Extended-Release Tablets, USP, 500 mg. The affected product is identified by Lot #C308195 with an expiration date of 10/2015. The bottles contain 100 tablets each and are labeled as Rx Only.
The recall was initiated because the tablets failed to meet dissolution specifications, specifically exceeding the specification at the 9-hour time point. This means the tablets may not release the medication into the body as intended.
The affected product was distributed nationwide. Consumers and healthcare providers should check their inventory for this specific lot number and expiration date. If found, the product should be returned to the pharmacy or point of purchase for a refund or replacement.
The recalled product
- Product
- DIVALPROEX SODIUM (DIVALPROEX SODIUM)
- Brand
- DIVALPROEX SODIUM
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 5,160
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #C308195
- exp 10/2015
UPCs (1)
- 0355111534013
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Dr. Reddy's Laboratories, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · DIVALPROEX SODIUM
- ModerateDivalproex Sodium Delayed-Release Tablets Recalled Due to Presence of Foreign Tablets
FDA (Drugs) · 2026-07-29
- HighDivalproex Sodium 250 mg tablets recalled for failed dissolution specifications
FDA (Drugs) · 2024-04-03
- HighDivalproex Sodium Extended-Release Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2022-08-31
- HighFDA Recalls Divalproex Sodium Tablets for Failed Dissolution Specifications
FDA (Drugs) · 2022-08-03
- ModerateMajor Pharmaceuticals Recalls Divalproex Sodium Tablets Due to Humidity Exposure
FDA (Drugs) · 2019-08-07
Same manufacturer · Dr. Reddy's Laboratories, Inc.
See all →- ModerateVarenicline tablets recalled after an assay value fell below specification
FDA (Drugs) · 2025-12-17
- Moderate
- HighOmeprazole capsule bottle contained a foreign divalproex sodium tablet
FDA (Drugs) · 2025-07-23
- SevereLevetiracetam Injection Label Mismatch Nationwide Recall
FDA (Drugs) · 2025-04-23
- ModerateFDA Recalls JAVYGTOR Tablets Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2024-12-18
Same hazard · dissolution failure
See all →- ModerateApotex Recalls Paxil Tablets for Failed Dissolution and Stability Testing
FDA (Drugs) · 2026-09-02
- ModerateMylan Recalls Acamprosate Calcium Tablets Due to Dissolution Failure
FDA (Drugs) · 2026-08-26
- ModerateChlorthalidone 25mg tablets failed dissolution specifications in two batches
FDA (Drugs) · 2026-06-24
- ModerateNiacin extended-release tablets failed dissolution testing at 24 hours
FDA (Drugs) · 2026-06-17
- ModerateMinocycline extended-release tablets failed dissolution testing during stability analysis
FDA (Drugs) · 2026-06-17